Chemical Structure (Glyburide 01)
Glyburide Tablet
Product Images NDC 0093-9477
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 0093-9477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (1.25 mg Tablet Bottle Label)
This text provides information regarding the dosage and administration of Glyburide USP tablets, containing 1.25 mg of glyburide, to be dispensed by a pharmacist. It instructs to keep the medication out of reach of children and to store it at a temperature of 25°C (77°F), with permitted excursions between 15-30°C. The text includes the NDC number for the tablets and the manufacturer's name and location. Origin information indicates that the medication was manufactured in India.*
Principal Display Panel (2.5 mg Tablet Bottle Label)
This is a medication containing 2.5 mg of glyburice USP per tablet. Dosage and administration guidance can be found in the package insert. The medicine should be kept out of reach of children and dispensed by a pharmacist. The medication should be stored in containers with safety clasps at a temperature of 25°F, with excursions permitted to 1°F as per USP Controlled Room Temperature guidelines. The medicine was manufactured in India and is distributed by Teva Pharmaceuticals.*
Principal Display Panel (5 mg Tablet Bottle Label)
This is a description of a medication named Glyburide, which comes in the form of USP tablets with a strength of 5mg. This medication needs to be kept out of reach of children, and the pharmacist should dispense it in a tightly closed container with safety closures. The medication has storage instructions that include keeping it at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The manufacturer of this medication is Teva Pharmaceuticals USA, Inc, originated in India, and last revised in June 2017.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
